financetom
Business
financetom
/
Business
/
Terex to Buy Dover's Environmental Solutions Group For $2 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Terex to Buy Dover's Environmental Solutions Group For $2 Billion
Jul 22, 2024 10:24 AM

01:09 PM EDT, 07/22/2024 (MT Newswires) -- Terex ( TEX ) announced plans to buy the environmental solutions business that includes waste and recycling equipment from Dover (DOV) for $2 billion in an all-cash deal.

Adjusted for the present value of expected tax benefits, the purchase price is $1.73 billion, according to Terex ( TEX ). This represents a multiple of about 8.4-times the business' 2024 estimated earnings before interest, taxes, depreciation and amortization, including anticipated synergies, Terex ( TEX ) said.

It expects roughly $25 million of cost and revenue synergies by 2026. Shares of Terex ( TEX ) jumped 9.7% in afternoon trade.

This acquisition marks "an incredibly exciting milestone in our multi-year transformation and aligns with our goal of strengthening our portfolio and leveraging our operating system to drive sustainable, accelerated long-term growth," Terex ( TEX ) Chief Executive Simon Meester said in a statement.

In a separate statement, Dover said the environmental solutions group, or ESG, generated about $750 million in revenue last year. Its products include refuse collection vehicles, compactors, and balers, as well as related aftermarket equipment and digital solutions. Shares of Dover were down 1.7%.

"ESG has been a part of the Dover family for decades and has created significant value for Dover shareholders over this time period," CEO Richard Tobin said.

The addition of ESG expands Terex's ( TEX ) North American addressable market while adding a non-cyclical, financially accretive business to its portfolio. The business has delivered a more than 7% long-term organic revenue compound annual growth rate over the last 10 years, said Terex ( TEX ), a maker of material handling equipment and aerial work platforms.

ESG's EBITDA margin including synergies are expected to add 130 basis points of margin accretion and boost Terex's ( TEX ) EBITDA to about $1 billion on a pro-forma basis. The deal is expected to be accretive by a double-digit percentage to adjusted EPS in 2025. Terex ( TEX ) is scheduled to report second-quarter results for its fiscal 2024 period on July 31.

Terex ( TEX ) said the transaction is expected to close in the second half of 2024, subject to regulatory approval, while Dover is forecasting a close before the end of 2024. Terex ( TEX ) has secured debt financing, which it will use along with cash to fund the purchase.

Price: 61.59, Change: +5.13, Percent Change: +9.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moody's Plans to Secure Majority Stake in Egyptian Credit Rating Agency Meris
Moody's Plans to Secure Majority Stake in Egyptian Credit Rating Agency Meris
Aug 25, 2025
08:27 AM EDT, 08/25/2025 (MT Newswires) -- Moody's (MCO) said Monday that it plans to secure a majority equity stake in Middle East Rating & Investors Service, a domestic credit rating agency in Egypt known as Meris. Financial terms of the deal, subject to regulatory approval, were not disclosed. Moody's said Meris, founded in 2003 as a joint venture between...
CareCloud Acquires Certain Assets of Medsphere Systems
CareCloud Acquires Certain Assets of Medsphere Systems
Aug 25, 2025
08:28 AM EDT, 08/25/2025 (MT Newswires) -- CareCloud ( CCLD ) said Monday it acquired certain assets of Medsphere Systems, a provider of health care IT software and related services to the US inpatient and ambulatory market. The purchase price was $16.5 million, half of which is in cash and the other half payable to Medsphere's secured bank lender under...
Immuneering Partners With Eli Lilly for Lung Cancer Drug Trials
Immuneering Partners With Eli Lilly for Lung Cancer Drug Trials
Aug 25, 2025
08:26 AM EDT, 08/25/2025 (MT Newswires) -- Immuneering ( IMRX ) said Monday it has entered into a clinical supply agreement with Eli Lilly ( LLY ) for its second-generation KRAS G12C inhibitor, olomorasib, aimed at non-small cell lung cancer. The company said the agreement supports evaluating atebimetinib, its lead product candidate and a novel dual MEK inhibitor that blocks...
BRIEF-Asset Entities Announces Shareholder Approval Vote For Merger With Strive To Be Held On Sept 9, 2025
BRIEF-Asset Entities Announces Shareholder Approval Vote For Merger With Strive To Be Held On Sept 9, 2025
Aug 25, 2025
Aug 25 (Reuters) - Asset Entities Inc ( ASST ): * ASSET ENTITIES ANNOUNCES S-4 DECLARED EFFECTIVE BY SEC AND SHAREHOLDER APPROVAL VOTE FOR MERGER WITH STRIVE TO BE HELD ON SEPTEMBER 9, 2025 Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved